The global hepatitis diagnostic test market size is expected to reach USD 8.4 billion by 2028 and register a CAGR of 6.8% according to the latest report by Reports and Data. Increasing funds by governments and various non-government organizations and rising need for early detection of hepatitis disease types are key factors fueling global market revenue growth.
Hepatitis is an inflammation of liver, commonly caused by a viral infection that can lead to various other complications such as liver cancer, liver cirrhosis, and liver fibrosis. There are five types of viral hepatitis, A, B, C, D, and E that have been affecting millions of people around the globe every year. Types of hepatitis can be diagnosed using various methods such as blood tests, liver biopsy, or imaging tests. Rising prevalence of hepatitis infection and growing need for hepatitis testing for effective treatment is fueling market growth. Increasing cases of hepatitis have also been associated with rising number of blood transfusions and donations. Reports have stated that there is a high risk of acquiring hepatitis B and C through blood transfusions. Moreover, various market players are investing in research and development activities to introduce novel and more effective products to expand their market footprint and product offerings.
However, high prices associated with testing, lack of mandate for nucleic acid amplification tests, and restricted access to low-cost and reliable diagnostic tests, especially in some developing countries, are key restraints that are expected to hamper revenue growth of the global hepatitis diagnostic test market to a certain extent during the forecast period.
Top Companies Profiled in the Report Include:
Siemens Healthineers, Roche, F. Hoffmann La-Roche, Abbott Laboratories, DiaSorin S.p.A, bioMeriuex, MedMira. Inc., Hologic, Inc., Danaher Corporation, Bio-Rad Laboratories, Qiagen, and Grifols, S.A.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4110
Market Overview:
The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/4110
The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, RD activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.
The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Hepatitis Diagnostic Test market in these key regions.
Country-wise regional analysis covers:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East Africa
To know more about the report @ https://www.reportsanddata.com/press-release/global-hepatitis-diagnostic-test-market
Additionally, the report consists a detailed analysis of the segmentation of the Hepatitis Diagnostic Test market based on product types and end-use/application offered in the Hepatitis Diagnostic Test market.
Diagnostic Tests Outlook (Revenue, USD Billion; 2018 - 2028)
- Blood tests
- Liver Function Tests
- Immunoassays
- Nucleic Acid Tests
- Imaging Tests
- Liver Biopsy
End User Outlook: (Revenue, USD Billion; 2018 - 2028)
- Hospitals
- Clinics
- Research Institutes
- Blood Banks
- Diagnostics laboratories
Read more report @
Computer Aided Detection Market - https://www.reportsanddata.com/report-detail/computer-aided-detection-cad-market
Hematology Diagnostics Market - https://www.reportsanddata.com/report-detail/hematology-diagnostics-market
Lateral Flow Assays Market - https://www.reportsanddata.com/report-detail/lateral-flow-assays-market
Heart Failure POC LOC Devices Market - https://www.reportsanddata.com/report-detail/heart-failure-poc-and-loc-devices-market
Primary Care POC Diagnostics Market - https://www.reportsanddata.com/report-detail/primary-care-poc-diagnostics-market
Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
